المؤلفون: Smit, E. F., Aerts, J. G., Muller, M., Niemeijer, A. L.N., Roder, H., Oliveira, C., Roder, J.

المصدر: Smit , E F , Aerts , J G , Muller , M , Niemeijer , A L N , Roder , H , Oliveira , C & Roder , J 2018 , ' Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii21 . https://doi.org/10.1093/annonc/mdy269.068

الاتاحة: https://research.vumc.nl/en/publications/9b4fd844-4f93-4ce8-abb9-9d47b1948fc2
https://doi.org/10.1093/annonc/mdy269.068
http://www.scopus.com/inward/record.url?scp=85078829722&partnerID=8YFLogxK

المؤلفون: Smit, E. F., Aerts, J. G., Muller, M., Niemeijer, A. L.N., Roder, H., Oliveira, C., Roder, J.

المصدر: Smit , E F , Aerts , J G , Muller , M , Niemeijer , A L N , Roder , H , Oliveira , C & Roder , J 2018 , ' Prediction of primary resistance to anti-PD1 therapy (APD1) in second-line NSCLC ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii21 . https://doi.org/10.1093/annonc/mdy269.068

Relation: https://research.vumc.nl/en/publications/9b4fd844-4f93-4ce8-abb9-9d47b1948fc2

الاتاحة: https://research.vumc.nl/en/publications/9b4fd844-4f93-4ce8-abb9-9d47b1948fc2
https://doi.org/10.1093/annonc/mdy269.068
http://www.scopus.com/inward/record.url?scp=85078829722&partnerID=8YFLogxK

المؤلفون: Smit, E.F., Aerts, J.G., Muller, M., Niemeijer, A.-L.N., Roder, H., Oliveira, C., Roder, J.

المصدر: Annals of Oncology ; volume 29, page viii21 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdy269.068
https://api.elsevier.com/content/article/PII:S0923753419484962?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419484962?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy269.068/26138962/mdy269.068.pdf